Epidemiological aspects of HTLV-III infection in Italy. 1985

P Rossi, and M Carbonari, and R Bonomo, and M Galli, and P E Manconi, and B Scarpati, and G Scano, and C Gaetano, and B Ensoli, and F Aiuti

An epidemiological survey on the presence of serum antibodies to human T lymphotropic retrovirus III (HTLV-III) is reported. The study was carried out on people living in large as well as small cities in different Italian regions. Serum samples of 21 patients with AIDS, 402 with ARCS, and 920 from individuals at risk for these diseases were analyzed. The percentage of positive sera varied from 81% in AIDS, to 100% -33.3% in ARC according to the different geographical areas and/or the various categories of people with ARC. The percentage of positive sera in individuals at risk for AIDS or ARC varied from 11.9% in homosexuals, to 21% in drug abusers and 23.1% in haemophiliacs. No positive sera were observed among 660 normal individuals, relatives of patients with AIDS or ARC and in 114 patients suffering from immunological or infectious disease and among people at risk living in small cities. Sera were also negative in patients with classical Kaposi's sarcoma or T-cell chronic lymphocytic leukemia. Since none of the 660 unselected normal adults were positive while a significant percentage of people at risk for AIDS showed antibodies to HTLV-III, we may presume that this infection is prevalent in the Italian categories in which AIDS and ARC are most likely to develop.

UI MeSH Term Description Entries
D007558 Italy A country in southern Europe, a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. The capital is Rome. Sardinia
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P Rossi, and M Carbonari, and R Bonomo, and M Galli, and P E Manconi, and B Scarpati, and G Scano, and C Gaetano, and B Ensoli, and F Aiuti
January 1972, Archivio Monaldi per la tisiologia e le malattie dell'apparato respiratorio,
P Rossi, and M Carbonari, and R Bonomo, and M Galli, and P E Manconi, and B Scarpati, and G Scano, and C Gaetano, and B Ensoli, and F Aiuti
January 2012, Frontiers in microbiology,
P Rossi, and M Carbonari, and R Bonomo, and M Galli, and P E Manconi, and B Scarpati, and G Scano, and C Gaetano, and B Ensoli, and F Aiuti
December 1985, Lancet (London, England),
P Rossi, and M Carbonari, and R Bonomo, and M Galli, and P E Manconi, and B Scarpati, and G Scano, and C Gaetano, and B Ensoli, and F Aiuti
April 1986, European journal of cancer & clinical oncology,
P Rossi, and M Carbonari, and R Bonomo, and M Galli, and P E Manconi, and B Scarpati, and G Scano, and C Gaetano, and B Ensoli, and F Aiuti
January 1985, Bollettino dell'Istituto sieroterapico milanese,
P Rossi, and M Carbonari, and R Bonomo, and M Galli, and P E Manconi, and B Scarpati, and G Scano, and C Gaetano, and B Ensoli, and F Aiuti
January 1987, Progress in clinical and biological research,
P Rossi, and M Carbonari, and R Bonomo, and M Galli, and P E Manconi, and B Scarpati, and G Scano, and C Gaetano, and B Ensoli, and F Aiuti
January 1959, Annali della sanita pubblica,
P Rossi, and M Carbonari, and R Bonomo, and M Galli, and P E Manconi, and B Scarpati, and G Scano, and C Gaetano, and B Ensoli, and F Aiuti
May 1985, The New Zealand medical journal,
P Rossi, and M Carbonari, and R Bonomo, and M Galli, and P E Manconi, and B Scarpati, and G Scano, and C Gaetano, and B Ensoli, and F Aiuti
March 1996, The West Indian medical journal,
P Rossi, and M Carbonari, and R Bonomo, and M Galli, and P E Manconi, and B Scarpati, and G Scano, and C Gaetano, and B Ensoli, and F Aiuti
January 1986, Scandinavian journal of social medicine,
Copied contents to your clipboard!